Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Frontiers in Neurology|November 14, 2025
A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in GermanyAchim Berthele, Clemens Gödel, Boris-Alexander Kallmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 14, 2020
Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerationsDominique Endres, Frank Leypoldt, Karl Bechter, et al.
Clinical Neurology and Neurosurgery|September 13, 2020
Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in GermanySebastian Rauer, Muna-Miriam Hoshi, Refik Pul, et al.
Frontiers in Psychiatry|September 14, 2020
Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal AntibodiesDominique Endres, Sebastian Rauer, Nils Venhoff, et al.
Frontiers in Neurology|November 22, 2019
Psychiatric Presentation of Anti-NMDA Receptor EncephalitisDominique Endres, Sebastian Rauer, Winfried Kern, et al.
Frontiers in Psychiatry|August 28, 2020
Novel Antineuronal Autoantibodies With Somatodendritic Staining Pattern in a Patient With Autoimmune PsychosisDominique Endres, Sebastian Rauer, Alexander Pschibul, et al.
Frontiers in Immunology|September 10, 2025
Case Report: Acute polymorphic psychosis and NMDA-R IgG antibodies in serum: a follow-up case studyKatharina von Zedtwitz, Judith Weiser, Raphael J Dressle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 19, 2019
Severe meningo-/encephalitis after daclizumab therapy for multiple sclerosisLidia Stork, Wolfgang Brück, Phillip von Gottberg, et al.
Annals of Neurology|September 24, 2022
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint InhibitorsXavier Boumaza, Baptiste Bonneau, Damien Roos-Weil, et al.
The Journal of Allergy and Clinical Immunology|April 1, 2014
Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosisHeiko Sic, Helene Kraus, Josef Madl, et al.
Pageof 8